Ankle Replacement

October 15, 2021

New U.S. Patent Approval for Episurf Medical

New U.S. Patent Approval for Episurf Medical
The patent is titled Determination and visualization of damage to an anatomical joint and relates to 3D-based assessment of joint lesions.
June 21, 2021

MatOrtho Gains Funding to Support Growth

MatOrtho Gains Funding to Support Growth
Private investor clients of Connection Capital, the specialist private client investment business, have invested £6.7 million (~USD $9.4 million) in MatOrtho, to support its international growth and product development....
June 1, 2021

Paragon 28 Acquires Assets of Additive Orthopaedics

Paragon 28 Acquires Assets of Additive Orthopaedics
The acquisition includes FDA approved, 3D-printed Patient Specific Talus Spacer for the Treatment of Avascular Necrosis for Humanitarian Use.
May 17, 2021

Kinos Medical Merges with restor3d

Kinos Medical Merges with restor3d
Kinos' portfolio mirrors the vision of Restor3d, where pre-operative planning, implant design and intra-op guidance is tailored to the patient and surgeon.
May 3, 2021

DJO Primed for Growth and Expansion in 2021

DJO Primed for Growth and Expansion in 2021
The company grew in the high single-digits for 1Q21 and strengthened finances to drive further acquisitions for its foot-and-ankle business.

Member-Only Content

SUBSCRIBE Login
April 20, 2021

Conformis Enters License Agreement with Paragon 28

Conformis Enters License Agreement with Paragon 28
Paragon 28 is granted a non-exclusive license for use of patient-specific instruments with off-the-shelf implants in Paragon 28's APEX 3D Total Ankle.
April 9, 2021

Episurf Medical Reaches Milestone of 1,000 Implants

Episurf Medical Reaches Milestone of 1,000 Implants
Over 450 patients have had the Episealer implant for more than two years, and approximately 80 patients have passed five years since surgery.
March 31, 2021

New U.S. Patent Approval for Episurf Medical

New U.S. Patent Approval for Episurf Medical
The patent relates to surgical instruments in the Episealer Talus technology for the ankle. This is the first approval in this specific patent family.
March 16, 2021

FDA Issues Safety Communication on STAR Ankle

FDA Issues Safety Communication on STAR Ankle
The notice relates to a higher than expected risk of fracture in the device's plastic component, as early as 3 to 4 years post-implantation.
February 15, 2021

Corin Appoints David Floyd as Interim CEO

Corin Appoints David Floyd as Interim CEO
Mr. Floyd's extensive industry experience includes roles at AxioMed Spine, Abbott Spine, DePuy Orthopaedics and Stryker Orthopaedics.
January 28, 2021

New U.S. Patent Approval for Episurf Medical

New U.S. Patent Approval for Episurf Medical
The patent relates to processes for individualized design with a focus on an insertion tool for the Episealer implants.
October 15, 2020

DJO Global Emerges as Buyer for Stryker Divestitures

DJO Global Emerges as Buyer for Stryker Divestitures
To clear regulatory issues related to its purchase of Wright Medical, Stryker proposed DJO as a buyer for certain ankle and finger joint replacement lines.
September 24, 2020

Kinos Medical Modernizes Ankle Replacement with New Technology

Kinos Medical Modernizes Ankle Replacement with New Technology
Historically, total ankle replacements have had low success rates compared to the more popular knee, hip and shoulder replacements. To put this into context, knee replacements have a success rate of nearly 96%, while ankle replacements succeed only 78% of the time, according to the American Academy of Orthopedic Surgeons. Patients opt for ankle fusion […]

Member-Only Content

SUBSCRIBE Login
July 24, 2020

Vilex Acquires DT MedTech and Hintermann Total Ankles

Vilex Acquires DT MedTech and Hintermann Total Ankles
The transaction includes the Hintermann H3 3-piece mobile-bearing prosthesis and the Hintermann H2 2-piece, semi-constrained prosthesis.
May 20, 2020

What Does the Next Generation of Total Ankles Need?

What Does the Next Generation of Total Ankles Need?
Preoperative planning, surgical instrumentation and bony ingrowth are advancements that surgeon Alan Davis, M.D., says are a must for future total ankles.
January 6, 2020

Episurf Medical Patent and Regulatory Updates

Episurf Medical Patent and Regulatory Updates
Episurf Medical received an additional patent in China relative to the Episealer® Femoral Twin joint implant design process and expects to obtain CE Mark Approval for the Episealer Talus ankle implant.
January 25, 2019

Foot and Ankle Implant Opportunities Lie in Design, Technique Improvements

The world of foot and ankle is vibrant and full of opportunity to solve real problems. Honesty in implant improvement must take place at the design stage. Foot and ankle has the trifecta of implants. Depending on the case, I need hardware, soft tissue reconstruction and a biologic enhancer. This is unique in orthopaedics, and the company that wins recognizes the problem to be solved in its totality and not just a piecemeal approach.
September 21, 2018

Joint Reconstruction Expected to Continue with Steady Growth

Joint Reconstruction Expected to Continue with Steady Growth
The 1H18 performance of companies that make up ~80% of the joint reconstruction market achieved 4.1% growth vs. 1H17. These companies posted 2.4% growth in 1H17 vs. 1H16. Here is a look at past activity and future predictions for hip, knee and extremities.

Member-Only Content

SUBSCRIBE Login
July 30, 2018

Integra LifeSciences Reports 2Q18 Revenue

ORTHOWORLD estimates Integra LifeSciences' 2Q18 orthopaedic revenue at US $30.4MM, -0.6% vs. 2Q17, and 1H18 revenue of $55.2MM, -2.5% vs. 1H17.

Member-Only Content

SUBSCRIBE Login
May 3, 2018

Stryker Posts 1Q18 Revenue

ORTHOWORLD estimates Stryker's 1Q18 orthopaedic revenue at US $1,724.9MM, +7.0% from 1Q17. 

Member-Only Content

SUBSCRIBE Login
March 26, 2018

Stryker Launches F1 Small Bone Power System

Stryker Instruments launched Stryker F1, a cordless, small footprint small bone power system for use in extremities procedures.
March 2, 2018

Integra LifeSciences Posts 4Q17, 2017 Revenue

ORTHOWORLD estimates Integra LifeSciences' 4Q17 orthopaedic revenue at US $27.42MM, +7.3% from 4Q16, and 2017 revenue of $107.8MM, +8.6% vs. 2016.

Member-Only Content

SUBSCRIBE Login
February 16, 2018

DT MedTech Announces Revision Procedures with H2 Ankle

DT MedTech announced successful ankle revision procedures with the Hintermann Series H2 Tibial Assembly component and PE inlay.
February 14, 2018

Episurf Medical to Launch Custom Ankle Implants

Episurf Medical is preparing to launch patient-specific Episealer® implants to treat osteochondral lesions in the ankle.
January 3, 2018

Articulus Bio Gains Funding, Focusing on Total Ankle Replacement

Articulus Bio received an undisclosed amount of funding that will support development of a total ankle replacement specifically addressing the issue of wear debris.
November 9, 2017

DT MedTech Receives FDA Clearance for Hintermann Total Ankle

DT MedTech received FDA 510(k) clearance to market the Hintermann Series H2™ Total Ankle, a semi-constrained, cemented prosthesis for primary or revision surgery.
November 8, 2017

Wright Medical 3Q17 Revenue +8% YoY

Wright Medical reported 3Q17 revenue of US $170.5MM, +8.4% from 3Q16, and YTD revenue of $527.4MM, +6.0% vs. the prior year.

Member-Only Content

SUBSCRIBE Login
November 7, 2017

Exactech Posts 3Q17 Revenue Growth

Exactech posted 3Q17 revenue of US $61.4MM, +2.6% vs. 3Q16, and YTD revenue of $198.2MM, +3.6% vs. the prior year.

Member-Only Content

SUBSCRIBE Login
November 2, 2017

Wright Medical INFINITY Postmarket Studies Update

Wright Medical announced the first patient implantation in a multi-center, 10-year U.S. follow-up study of the INFINITY™ Total Ankle.
October 31, 2017

Integra LifeSciences Posts 3Q17 Revenue

ORTHOWORLD estimates Integra LifeSciences' 3Q17 orthopaedic revenue at US $26.2MM, +4.8% from 3Q16, and year-to-date revenue of $80.3MM, +9.1% vs. the prior year.

Member-Only Content

SUBSCRIBE Login
September 22, 2017

Integra Enrollment in Cadence Total Ankle Postmarket Study

Integra LifeSciences implanted the first Cadence® Total Ankle as part of a non-randomized, prospective, multi-center postmarket study.
August 7, 2017

Wright Medical 2Q17 Revenue

Wright Medical reported 2Q17 revenue of US $179.7MM, +5.3% from 2Q16, and 1H17 revenue of $356.9MM, +5.0% vs. 1H16.

Member-Only Content

SUBSCRIBE Login
August 1, 2017

Integra LifeSciences 2Q17 Orthopaedic Revenue

ORTHOWORLD estimates Integra LifeSciences' 2Q17 orthopaedic revenue at US $37.3MM, +34.1% from 2Q16, and 1H17 revenue of $68.5MM, +27.1% vs. 1H16.

Member-Only Content

SUBSCRIBE Login
May 9, 2017

Wright Medical’s 1Q17 Revenue

Wright Medical reported 1Q17 revenue of US $177.2MM, +4.7% from 1Q16. (U.S. $132.1MM, +6.1%; ex-U.S. $45.0MM, +0.6%)

Member-Only Content

SUBSCRIBE Login
May 1, 2017

Integra Posts 1Q17 Revenue

ORTHOWORLD estimates Integra LifeSciences' 1Q17 orthopaedic revenue at US $31.2MM, +19.6% from 1Q16.

Member-Only Content

SUBSCRIBE Login
March 28, 2017

Commercial Expansion of Cadence Total Ankle

Integra LifeSciences commenced full commercial launch of the Cadence® Total Ankle in Canada, the U.S. and select EU regions.
February 8, 2017

Ex-US Launch of Zimmer Biomet’s Subchondroplasty

Zimmer Biomet commenced international release of the Subchondroplasty® procedure (SCP®), following its approval under the CE Mark. 
December 19, 2016

Australian Joint Registry Data for DePuy’s ATTUNE Knee

Implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry confirm positive early results for DePuy Synthes' ATTUNE® Knee. 
October 13, 2016

First Surgery with Exactech Vantage Total Ankle

Exactech announced successful completion of the first surgery using the Vantage® Total Ankle. Full U.S. market launch is slated for 2017.
April 25, 2016

Exactech Receives FDA 510(k) Clearance for Vantage Total Ankle

Exactech received FDA 510(k) clearance to market the Vantage™ Total Ankle. Targeted clinical evaluation will commence in mid-2016, with full launch slated for 1Q17.